logo
Galaxy Announces Final Close of Oversubscribed Galaxy Ventures Fund I at Over $175M

Galaxy Announces Final Close of Oversubscribed Galaxy Ventures Fund I at Over $175M

Galaxy Ventures raises its inaugural venture fund with the support of a global base of limited partners to back early-stage startups building the onchain economy
NEW YORK, June 26, 2025 /PRNewswire/ - Galaxy Asset Management, an affiliate of Galaxy Digital Inc. (NASDAQ: GLXY) (TSX: GLXY) and one of the world's largest digital asset and blockchain investment managers, today announced the final close of its oversubscribed Galaxy Ventures Fund I, LP ('GVF I' or 'the Fund'). Driven by strong investor demand for access to the growing digital asset venture ecosystem, the Fund closed with over $175 million in capital commitments, exceeding its target of $150 million.
The Fund is focused on investing in early-stage companies developing critical infrastructure and applications for the onchain economy. Its investment strategy spans the categories of financialized applications, blockchain protocols, and software infrastructure. The Fund specifically has and will continue to target investments in secular growth areas like stablecoins, payments, and tokenization, plus all the supporting infrastructure that makes such technologies viable.
This milestone marks a new chapter for Galaxy Ventures, which had previously invested from Galaxy's balance sheet since 2018. Given Galaxy Ventures' strong track record of supporting visionary founders at the earliest stages, GVF I attracted a diverse group of limited partners, including institutional investors, family offices, and strategic digital asset businesses. The portfolio already includes some of the most promising startups in the space such as 1Money, Arch Lending, Ethena, M^0, Monad, Plume, Rail, Rain, RedotPay, Ubyx, and Yellow Card, among others. Including historical balance sheet investments and the current GVF I portfolio, Galaxy Ventures has backed more than 120 companies to date.
'Galaxy Ventures closing its first fund above the target at a time when raising crypto venture is historically difficult showcases our team's unique edge in the market,' said Mike Novogratz, Founder and Chief Executive Officer of Galaxy. 'With deep roots in onchain markets and blockchain infrastructure, we're committed to backing founders and startups building real-world use cases that are shaping the next chapter of crypto adoption.'
The Galaxy Ventures team is headed by Will Nuelle and Mike Giampapa. They are supported by a team of investors and a dedicated Ventures Platform function that directly supports portfolio companies with in-house company building resources and connectivity to Galaxy's global business lines including blockchain infrastructure, lending, trading, and more. With a global team of more than 550 employees, Galaxy offers portfolio companies deep industry connectivity, insight, and access to growth opportunities that help portfolio companies navigate the rapidly shifting crypto landscape.
'Blockchain infrastructure is poised to revolutionize global financial markets. We're seeing an acceleration of adoption from both institutions and retail users globally—especially around use cases like payments, capital markets, and financial services more broadly,' said Mike Giampapa. 'By investing in the teams that are building these core technologies and supporting their growth directly, we have a front-row seat to the most novel concepts and products in crypto.'
About Galaxy
Galaxy (NASDAQ/TSX: GLXY) is a global leader in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. Our digital assets platform offers institutional access to trading, investment banking, asset management, staking, self-custody, and tokenization technology. In addition, we invest in and operate cutting-edge data center infrastructure to power AI and high-performance computing, meeting the growing demand for scalable energy and compute solutions in the U.S. The company is headquartered in New York City, with offices across North America, Europe, the Middle East and Asia. Additional information about Galaxy's businesses and products is available on www.galaxy.com.
Disclaimers and Additional Information
The TSX has not approved or disapproved of the information contained herein.
CAUTION ABOUT FORWARD-LOOKING STATEMENTS
This release contains certain forward-looking information and forward-looking statements, as defined in applicable securities laws (collectively referred to herein as 'forward-looking statements'). These forward-looking statements relate to the Tokenization Wizard launch and opportunities. All statements other than statements of historical fact are forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as 'plans', 'expects', 'budget', 'scheduled', 'estimates', 'continues', 'forecasts', 'projects', 'predicts', 'intends', 'anticipates' or 'believes', 'seeks' or variations of, or the negatives of, such words and phrases, or state that certain actions, events or results 'may', 'could', 'would', 'should', 'might' or 'will' be taken, occur or be achieved. The forward-looking statements contained in this release are based on our current expectations and beliefs concerning future developments and their potential effects on us taking into account information currently available to us. There can be no assurance that future developments affecting us will be those that we have anticipated. Forward-looking statements involve known and unknown risks uncertainties and other factors that may cause actual results to differ materially from those anticipated in such forward-looking statements. Inherent in forward-looking statements are risks, uncertainties and other factors beyond the Company's ability to predict or control. The forward-looking statements are subject to the risks regarding the product and launch. Factors that could cause outcomes to differ materially from those described in such forward-looking statements include, but are not limited to global developments, a delay or failure in the ability to launch and changes in applicable law or regulation. Readers are cautioned that such risk factors, uncertainties and other factors are not exhaustive. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements in this release. The forward-looking statements in this release are applicable only as of the date of this release or as of the date specified in the relevant forward-looking statement and the Company does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by applicable securities laws. Investors are cautioned that forward-looking statements are not guarantees of future performance and are inherently uncertain. Accordingly, investors are cautioned not to put undue reliance on forward-looking statements.
View original content to download multimedia: https://www.prnewswire.com/news-releases/galaxy-announces-final-close-of-oversubscribed-galaxy-ventures-fund-i-at-over-175m-302491684.html
SOURCE Galaxy Digital Inc.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

When Should You Buy Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL)?
When Should You Buy Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL)?

Yahoo

time39 minutes ago

  • Yahoo

When Should You Buy Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL)?

While Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL) might not have the largest market cap around , it saw a significant share price rise of 72% in the past couple of months on the NASDAQGS. The company is inching closer to its yearly highs following the recent share price climb. As a stock with high coverage by analysts, you could assume any recent changes in the company's outlook is already priced into the stock. But what if there is still an opportunity to buy? Let's examine Cracker Barrel Old Country Store's valuation and outlook in more detail to determine if there's still a bargain opportunity. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. According to our price multiple model, which makes a comparison between the company's price-to-earnings ratio and the industry average, the stock price seems to be justfied. We've used the price-to-earnings ratio in this instance because there's not enough visibility to forecast its cash flows. The stock's ratio of 23.32x is currently trading slightly below its industry peers' ratio of 23.52x, which means if you buy Cracker Barrel Old Country Store today, you'd be paying a decent price for it. And if you believe Cracker Barrel Old Country Store should be trading in this range, then there isn't much room for the share price to grow beyond the levels of other industry peers over the long-term. So, is there another chance to buy low in the future? Given that Cracker Barrel Old Country Store's share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us an opportunity to buy later on. This is based on its high beta, which is a good indicator for share price volatility. Check out our latest analysis for Cracker Barrel Old Country Store Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. With profit expected to grow by 27% over the next couple of years, the future seems bright for Cracker Barrel Old Country Store. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation. Are you a shareholder? CBRL's optimistic future growth appears to have been factored into the current share price, with shares trading around industry price multiples. However, there are also other important factors which we haven't considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at CBRL? Will you have enough conviction to buy should the price fluctuate below the industry PE ratio? Are you a potential investor? If you've been keeping an eye on CBRL, now may not be the most optimal time to buy, given it is trading around industry price multiples. However, the optimistic forecast is encouraging for CBRL, which means it's worth further examining other factors such as the strength of its balance sheet, in order to take advantage of the next price drop. If you want to dive deeper into Cracker Barrel Old Country Store, you'd also look into what risks it is currently facing. For example - Cracker Barrel Old Country Store has 2 warning signs we think you should be aware of. If you are no longer interested in Cracker Barrel Old Country Store, you can use our free platform to see our list of over 50 other stocks with a high growth potential. — Investing narratives with Fair Values A case for TSXV:USA to reach USD $5.00 - $9.00 (CAD $7.30–$12.29) by 2029. By Agricola – Community Contributor Fair Value Estimated: CA$12.29 · 0.9% Overvalued DLocal's Future Growth Fueled by 35% Revenue and Profit Margin Boosts By WynnLevi – Community Contributor Fair Value Estimated: $195.39 · 0.9% Overvalued Historically Cheap, but the Margin of Safety Is Still Thin By Mandelman – Community Contributor Fair Value Estimated: SEK232.58 · 0.1% Overvalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Will Artiva Biotherapeutics (NASDAQ:ARTV) Spend Its Cash Wisely?
Will Artiva Biotherapeutics (NASDAQ:ARTV) Spend Its Cash Wisely?

Yahoo

time2 hours ago

  • Yahoo

Will Artiva Biotherapeutics (NASDAQ:ARTV) Spend Its Cash Wisely?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although software-as-a-service business lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. Having said that, unprofitable companies are risky because they could potentially burn through all their cash and become distressed. So should Artiva Biotherapeutics (NASDAQ:ARTV) shareholders be worried about its cash burn? For the purpose of this article, we'll define cash burn as the amount of cash the company is spending each year to fund its growth (also called its negative free cash flow). First, we'll determine its cash runway by comparing its cash burn with its cash reserves. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. A cash runway is defined as the length of time it would take a company to run out of money if it kept spending at its current rate of cash burn. In March 2025, Artiva Biotherapeutics had US$166m in cash, and was debt-free. In the last year, its cash burn was US$61m. So it had a cash runway of about 2.7 years from March 2025. That's decent, giving the company a couple years to develop its business. The image below shows how its cash balance has been changing over the last few years. See our latest analysis for Artiva Biotherapeutics Because Artiva Biotherapeutics isn't currently generating revenue, we consider it an early-stage business. So while we can't look to sales to understand growth, we can look at how the cash burn is changing to understand how expenditure is trending over time. Over the last year its cash burn actually increased by 23%, which suggests that management are increasing investment in future growth, but not too quickly. That's not necessarily a bad thing, but investors should be mindful of the fact that will shorten the cash runway. While the past is always worth studying, it is the future that matters most of all. So you might want to take a peek at how much the company is expected to grow in the next few years. Given its cash burn trajectory, Artiva Biotherapeutics shareholders may wish to consider how easily it could raise more cash, despite its solid cash runway. Issuing new shares, or taking on debt, are the most common ways for a listed company to raise more money for its business. Commonly, a business will sell new shares in itself to raise cash and drive growth. By comparing a company's annual cash burn to its total market capitalisation, we can estimate roughly how many shares it would have to issue in order to run the company for another year (at the same burn rate). Since it has a market capitalisation of US$36m, Artiva Biotherapeutics' US$61m in cash burn equates to about 170% of its market value. That suggests the company may have some funding difficulties, and we'd be very wary of the stock. Even though its cash burn relative to its market cap makes us a little nervous, we are compelled to mention that we thought Artiva Biotherapeutics' cash runway was relatively promising. Even though we don't think it has a problem with its cash burn, the analysis we've done in this article does suggest that shareholders should give some careful thought to the potential cost of raising more money in the future. On another note, Artiva Biotherapeutics has 5 warning signs (and 3 which are potentially serious) we think you should know about. If you would prefer to check out another company with better fundamentals, then do not miss this free list of interesting companies, that have HIGH return on equity and low debt or this list of stocks which are all forecast to grow. — Investing narratives with Fair Values A case for TSXV:USA to reach USD $5.00 - $9.00 (CAD $7.30–$12.29) by 2029. By Agricola – Community Contributor Fair Value Estimated: CA$12.29 · 0.9% Overvalued DLocal's Future Growth Fueled by 35% Revenue and Profit Margin Boosts By WynnLevi – Community Contributor Fair Value Estimated: $195.39 · 0.9% Overvalued Historically Cheap, but the Margin of Safety Is Still Thin By Mandelman – Community Contributor Fair Value Estimated: SEK232.58 · 0.1% Overvalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Establishment Labs Holdings' (NASDAQ:ESTA) growing losses don't faze investors as the stock climbs 8.3% this past week
Establishment Labs Holdings' (NASDAQ:ESTA) growing losses don't faze investors as the stock climbs 8.3% this past week

Yahoo

time2 hours ago

  • Yahoo

Establishment Labs Holdings' (NASDAQ:ESTA) growing losses don't faze investors as the stock climbs 8.3% this past week

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company that is really flourishing, you can make more than 100%. One great example is Establishment Labs Holdings Inc. (NASDAQ:ESTA) which saw its share price drive 121% higher over five years. And in the last month, the share price has gained 19%. Since it's been a strong week for Establishment Labs Holdings shareholders, let's have a look at trend of the longer term fundamentals. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Given that Establishment Labs Holdings didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. When a company doesn't make profits, we'd generally hope to see good revenue growth. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size. In the last 5 years Establishment Labs Holdings saw its revenue grow at 14% per year. That's a pretty good long term growth rate. Broadly speaking, this solid progress may well be reflected by the healthy share price gain of 17% per year over five years. Given that the business has made good progress on the top line, it would be worth taking a look at the growth trend. When a growth trend accelerates, be it in revenue or earnings, it can indicate an inflection point for the business, which is can often be an opportunity for investors. The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image). It's probably worth noting that the CEO is paid less than the median at similar sized companies. It's always worth keeping an eye on CEO pay, but a more important question is whether the company will grow earnings throughout the years. If you are thinking of buying or selling Establishment Labs Holdings stock, you should check out this free report showing analyst profit forecasts. While the broader market gained around 15% in the last year, Establishment Labs Holdings shareholders lost 9.9%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. On the bright side, long term shareholders have made money, with a gain of 17% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For example, we've discovered 2 warning signs for Establishment Labs Holdings that you should be aware of before investing here. Of course Establishment Labs Holdings may not be the best stock to buy. So you may wish to see this free collection of growth stocks. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store